RARE
Ultragenyx Pharmaceutical
$26.89
−$0.01 (−0.04%)Jul 27, 2026
Key metrics
The numbers that frame RARE today
- Market cap
- $2.65B
- P/E (TTM)
- -4.3
- EV / FCF
- -7.3
- Gross margin
- 83.5%
- EV / Sales
- 5.5
- ROIC
- -38.2%
- Div yield
- 0%
- 52wk Low
- $18.29
- 52wk High
- $39.89
Growth
Revenue and earnings trend for RARE
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about RARE
Is Ultragenyx Pharmaceutical a good buy?
Hold. Ultragenyx Pharmaceutical has mixed quality and strong momentum. The setup is mixed. Growth looks poor. That could put pressure on the long-term business case. We think Ultragenyx Pharmaceutical is selling at a very high price.
What is the market capitalization of RARE?
Ultragenyx Pharmaceutical's market capitalization is $2.65B.
What is the P/E ratio for RARE stock?
Ultragenyx Pharmaceutical's current P/E ratio is -4.3.
What is the 52-week high for RARE stock?
The 52-week high for Ultragenyx Pharmaceutical is $39.89. The current close of $26.89 is 32.6% below that high.
What is the 52-week low for RARE stock?
The 52-week low for Ultragenyx Pharmaceutical is $18.29. The current close of $26.89 is 47% above that low.
Does RARE stock pay dividends?
Ultragenyx Pharmaceutical does not currently show a dividend per share in the company data.